FDA Clearance Tracker · P040044-S038
MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY
Last checked: Nov 20, 2026Latest source record: Jul 21, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jul 21, 2011
Approved
Time to decision
55 days
Received May 27, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040044-S038
- Device name
- MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- May 27, 2011
- Decided
- Jul 21, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A CONTRACT STERILIZATION SITE, BEAMONE, LLC LOCATED IN MOUNTAIN VIEW, CALIFORNIA.
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.